Sign In
Buy CYTK
$80.01
+0.84 (+1.06%)
At Close: Jun 23, 2026
Cytokinetics (NASDAQ:CYTK) Price Target Increased to $23.00 by Analysts at Cantor Fitzgerald
09:48am, Tuesday, 21'st Apr 2020
Cytokinetics (NASDAQ:CYTK) had its price objective boosted by Cantor Fitzgerald from $12.00 to $23.00 in a research report report published on Friday, Benzinga reports. Cantor Fitzgerald currently has
Morgan Stanley Upgrades Cytokinetics (NASDAQ:CYTK) to Overweight
06:04am, Tuesday, 21'st Apr 2020
Cytokinetics (NASDAQ:CYTK) was upgraded by equities research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report issued on Sunday, Benzinga reports.
Cubist Systematic Strategies LLC Sells 13,419 Shares of Cytokinetics, Inc. (NASDAQ:CYTK)
09:18am, Monday, 20'th Apr 2020
Cubist Systematic Strategies LLC reduced its stake in Cytokinetics, Inc. (NASDAQ:CYTK) by 81.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Cytokinetics, Inc. (NASDAQ:CYTK) Stake Increased by Alliancebernstein L.P.
08:30am, Sunday, 19'th Apr 2020
Alliancebernstein L.P. increased its holdings in shares of Cytokinetics, Inc. (NASDAQ:CYTK) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch
Analysts Expect Cytokinetics, Inc. (NASDAQ:CYTK) Will Announce Earnings of -$0.50 Per Share
09:58am, Saturday, 18'th Apr 2020
Analysts forecast that Cytokinetics, Inc. (NASDAQ:CYTK) will report ($0.50) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Cytokinetics’ earn
The Cytokinetics (NASDAQ:CYTK) Share Price Is Up 93% And Shareholders Are Holding On
05:02pm, Friday, 17'th Apr 2020
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...
10 Biggest Price Target Changes For Friday
12:14pm, Friday, 17'th Apr 2020
Goldman Sachs cut Apple Inc. (NASDAQ: AAPL) price target from $250 to $233. Apple shares closed at $286.69 on Thursday.
Raymond James lowered the price target on Union Pacific...
Cytokinetics price target raised to $23 from $12 at Cantor Fitzgerald CYTK
11:39am, Friday, 17'th Apr 2020
Cytokinetics price target raised to $23 from $12 at Cantor Fitzgerald Cantor Fitzgerald CYTK
$4.92 Million in Sales Expected for Cytokinetics, Inc. (NASDAQ:CYTK) This Quarter
05:16am, Friday, 17'th Apr 2020
Brokerages expect Cytokinetics, Inc. (NASDAQ:CYTK) to report sales of $4.92 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Cytokinetics’ e
Cantor Fitzgerald Reiterates Overweight on Cytokinetics, Raises Price Target to $23
12:00am, Friday, 17'th Apr 2020Cytokinetics (NASDAQ:CYTK) Stock Rating Reaffirmed by Needham & Company LLC
07:34am, Thursday, 16'th Apr 2020
Cytokinetics (NASDAQ:CYTK)‘s stock had its “buy” rating restated by Needham & Company LLC in a research note issued on Tuesday, AnalystRatings.com reports. They currently have a $24.00 target pr
Morgan Stanley Sticks to Its Hold Rating for Voyager Therapeutics (VYGR)
03:43pm, Wednesday, 15'th Apr 2020
In a report released today, Jeffrey Hung from Morgan Stanley maintained a Hold rating on Voyager Therapeutics (VYGR), with a price target of $13.00. The
Cytokinetics (NASDAQ:CYTK) Rating Reiterated by HC Wainwright
07:34am, Wednesday, 15'th Apr 2020
Cytokinetics (NASDAQ:CYTK)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Tuesday, TipRanks reports. They presently have a $30.0
Cytokinetics (CYTK) Received its Third Buy in a Row
03:16pm, Tuesday, 14'th Apr 2020
After Morgan Stanley and Needham gave Cytokinetics (NASDAQ: CYTK) a Buy rating last month, the company received another Buy, this time from H.C.
Cytokinetics (CYTK) Received its Third Buy in a Row
03:15pm, Tuesday, 14'th Apr 2020
After Morgan Stanley and Needham gave Cytokinetics (NASDAQ: CYTK) a Buy rating last month, the company received another Buy, this
